Showing 1 - 5 results of 5 for search 'Akihito Tsubota', query time: 0.01s Refine Results
  1. 1
    CRISPR/Cas9-mediated RELA and RELC knockout in human regulatory T cells abrogates FOXP3 expression and suppressive function

    CRISPR/Cas9-mediated RELA and RELC knockout in human regulatory T cells abrogates FOXP3 expression and suppressive function by Yohei Sato, Yamato Hanawa, Akihito Tsubota

    Published 2024-12-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    Bioelectrical impedance analysis-derived phase angle predicts osteosarcopenia and mortality in patients with chronic liver disease

    Bioelectrical impedance analysis-derived phase angle predicts osteosarcopenia and mortality in patients with chronic liver disease by Kohei Nishiwaki, Chisato Saeki, Tomoya Kanai, Manabu Sunayama, Yuki Tamura, Takashi Niwa, Sachie Kiryu, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota

    Published 2025-07-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Impact of frailty and prevalent fractures on the long-term prognosis of patients with cirrhosis: a retrospective study

    Impact of frailty and prevalent fractures on the long-term prognosis of patients with cirrhosis: a retrospective study by Takashi Niwa, Chisato Saeki, Mitsuru Saito, Tsunekazu Oikawa, Hiroshi Kamioka, Tomoya Kanai, Kaoru Ueda, Masanori Nakano, Yuichi Torisu, Masayuki Saruta, Akihito Tsubota

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis

    Identification of circulating microRNAs as potential biomarkers for hepatic necroinflammation in patients with autoimmune hepatitis by Koji Fujita, Juntaro Matsuzaki, Satoko Takizawa, Takahiro Ochiya, Masayuki Saruta, Yasuni Nakanuma, Chisato Saeki, Masahiko Kuroda, Makiko Ichikawa, Keiko Takano, Tsunekazu Oikawa, Akihito Tsubota

    Published 2022-10-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naïve Genotype 1b Chronic Hepatitis C Patients

    Predictors of Response to 24-Week Telaprevir-Based Triple Therapy for Treatment-Naïve Genotype 1b Chronic Hepatitis C Patients by Hiroshi Abe, Akihito Tsubota, Noritomo Shimada, Masanori Atsukawa, Keizo Kato, Koichi Takaguchi, Toru Asano, Yoshimichi Chuganji, Choitsu Sakamoto, Hidenori Toyoda, Takashi Kumada, Tatsuya Ide, Michio Sata, Yoshio Aizawa

    Published 2014-01-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: